Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Peter Thuss‐Patience, B. Gahn, Guido Schumacher et al.|Annals of Oncology|2012Cited by 70
FOLFOX/bevacizumab +/- irinotecan in advanced colorectal cancer (CHARTA): Long term outcomeHans‐Joachim Schmoll, Annette Stein, Benjamin Garlipp et al.|Annals of Oncology|2018Cited by 15
Perioperative chemotherapy with docetaxel, cisplatin, and capecitabine (DCX) in gastroesophageal adenocarcinoma: A phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).Peter Thuss‐Patience, Michael Kneba, Ralf‐Dieter Hofheinz et al.|Journal of Clinical Oncology|2011Cited by 4
FOLFOX / Bevacizumab (Beva) +/- Irinotecan in advanced colorectal cancer (CRC): A randomized phase II trial (AIO KRK 0209, CHARTA)Hans‐Joachim Schmoll, Alexander Stein, Benjamin Garlipp et al.|Annals of Oncology|2016Cited by 1
Docetaxel, cisplatin, and capecitabine (DCX) as perioperative chemotherapy in gastroesophageal adenocarcinoma: A phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).Peter Thuss‐Patience, Guido Schumacher, Michael Kneba et al.|Journal of Clinical Oncology|2010Cited by 1